PJP vs. IHI
PJP (Invesco Dynamic Pharmaceuticals ETF) and IHI (iShares U.S. Medical Devices ETF) are both Health & Biotech Equities funds - PJP tracks the Dynamic Pharmaceuticals Intellidex Index while IHI tracks the Dow Jones U.S. Select Medical Equipment Index. Both are passively managed. Over the past 10 years, PJP returned 7.25%/yr vs 8.71%/yr for IHI. A 0.70 correlation means they provide meaningful diversification when combined. PJP charges 0.58%/yr vs 0.38%/yr for IHI.
Performance
PJP vs. IHI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 7.87% return, which is significantly higher than IHI's -22.04% return. Over the past 10 years, PJP has underperformed IHI with an annualized return of 7.25%, while IHI has yielded a comparatively higher 8.71% annualized return.
PJP
- 1D
- 0.70%
- 1M
- 3.08%
- YTD
- 7.87%
- 6M
- 4.83%
- 1Y
- 42.28%
- 3Y*
- 15.13%
- 5Y*
- 8.22%
- 10Y*
- 7.25%
IHI
- 1D
- -1.49%
- 1M
- -4.26%
- YTD
- -22.04%
- 6M
- -23.22%
- 1Y
- -19.49%
- 3Y*
- -4.08%
- 5Y*
- -3.72%
- 10Y*
- 8.71%
PJP vs. IHI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 7.87% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
IHI iShares U.S. Medical Devices ETF | -22.04% | 6.88% | 8.62% | 3.24% | -19.80% | 21.03% | 24.17% | 32.75% | 15.45% | 30.81% |
Correlation
The correlation between PJP and IHI is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.64 |
Correlation (All Time) Calculated using the full available price history since May 5, 2006 | 0.70 |
Over the past year, the correlation between PJP and IHI has dropped to 0.47 - well below their long-term average of 0.70, suggesting their price drivers have been diverging.
PJP vs. IHI - Sectors Allocation Comparison
Sectors
PJP
IHI
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
IHI
Financial Services
PJP
IHI
-
Basic Materials
PJP
-
IHI
-
Communication Services
PJP
-
IHI
-
Consumer Cyclical
PJP
-
IHI
-
Consumer Defensive
PJP
-
IHI
-
Energy
PJP
-
IHI
-
Industrials
PJP
-
IHI
Real Estate
PJP
-
IHI
-
Technology
PJP
-
IHI
-
Utilities
PJP
-
IHI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. IHI — Risk / Return Rank
PJP
IHI
PJP vs. IHI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PJP | IHI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.69 | ||
| Sortino ratioReturn per unit of downside risk | +5.16 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 0.83 | +0.60 |
| Calmar ratioReturn relative to maximum drawdown | 4.50 | -0.75 | +5.25 |
| Martin ratioReturn relative to average drawdown | 14.26 | -1.72 | +15.98 |
Loading charts...
Drawdowns
PJP vs. IHI - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum IHI drawdown of -49.65%. Use the drawdown chart below to compare losses from any high point for PJP and IHI.
Loading charts...
Drawdown Indicators
| PJP | IHI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -49.65% | +12.59% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -26.11% | +16.67% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -26.64% | +10.37% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -33.12% | +15.61% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -33.25% | -0.70% |
Current DrawdownCurrent decline from peak | -1.26% | -26.39% | +25.13% |
Average DrawdownAverage peak-to-trough decline | -8.83% | -8.35% | -0.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.97% | 11.34% | -8.37% |
Volatility
PJP vs. IHI - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.20%, while iShares U.S. Medical Devices ETF (IHI) has a volatility of 6.52%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | IHI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.20% | 6.52% | -1.32% |
Volatility (6M)Calculated over the trailing 6-month period | 12.34% | 13.71% | -1.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.54% | 17.57% | -1.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.19% | 19.07% | -2.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 19.84% | -1.45% |
PJP vs. IHI - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is higher than IHI's 0.38% expense ratio.
Dividends
PJP vs. IHI - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 1.19%, more than IHI's 0.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHI iShares U.S. Medical Devices ETF | 0.50% | 0.34% | 0.46% | 0.53% | 0.45% | 0.25% | 0.25% | 0.33% | 0.26% | 0.37% | 0.55% | 1.28% |
PJP Invesco Dynamic Pharmaceuticals ETF | 1.19% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
Frequently Asked Questions
PJP and IHI have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHI has higher volatility (6.52%) compared to PJP (5.20%). In terms of maximum drawdown, PJP dropped -37.06% vs IHI's -49.65%.
On 10-year performance, IHI leads with 8.71% vs 7.25% for PJP. On fees, IHI is cheaper at 0.38% per year. On volatility, PJP has been the lower-risk option at 5.20%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHI has performed better with a 8.71% return vs 7.25%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHI is cheaper with a 0.38% expense ratio, compared with 0.58% for PJP.
PJP has the higher dividend yield at 1.19%, compared with 0.50% for IHI.
PJP tracks Dynamic Pharmaceuticals Intellidex Index, while IHI tracks Dow Jones U.S. Select Medical Equipment Index. They also come from different issuers: Invesco and iShares. Their fees differ too: 0.58% for PJP and 0.38% for IHI.
PJP currently has the higher Sharpe Ratio (2.57 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and IHI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer